此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Genetic Factors in Atherosclerosis

Chemokine System Polymorphisms and Risk of Atherosclerosis (CAD)

The purpose of this study is to identify genes associated with certain risk factors for atherosclerosis (hardening of the arteries) and its consequences, such as development of coronary artery disease, heart attack, other blood vessel disease and stroke.

People enrolled in the Framingham Heart Study in Framingham, Massachusetts, are eligible to participate in this study. They will undergo a medical history, including review of their medical records and a family history; evaluation of memory and mood; breathing test and electrocardiogram (EKG); blood and urine tests, including blood sample collection for DNA (genetic) testing; evaluation of gait (walking), balance and hand grip strength; and hearing test. They will also fill out questionnaires on their eating habits and general health.

Any patients who may suffer a stroke during the study will be examined during their hospitalization and at 3, 6, 12, and 24 months after the stroke. This examination includes a neurological evaluation, assessment of ability to perform daily living tasks and, possibly, magnetic resonance imaging (MRI) of the brain, a test that uses a strong magnetic field and radio waves to produce pictures of the brain.

研究概览

地位

完全的

详细说明

We are studying the relationship between genetic variants of the human immune system and atherosclerosis through a collaboration with the Framingham Heart Study. Since atherosclerosis is a disease of chronic inflammation of the arterial vessel wall, genetic variants in molecules that are responsible for the migration of leukocytes are likely to explain some of the genetic diversity in the rate of heart disease and strokes. Therefore we are conducting a molecular epidemiology study of the genetics of atherosclerosis using materials and clinical data already collected by the Framingham Heart Study. The Heart Study is a prospective epidemiological study of the natural history of heart disease and stroke that has involved individuals residing in Framingham, Massachusetts since the 1950s. We will compare risks of individuals with particular genotypes for developing atherosclerosis and its sequelae, coronary artery disease, heart attack, peripheral vascular disease, and stroke. If correlations of genotype with risk of atherosclerosis can be found, then this will facilitate new treatments of this disease based on interference with particular components of the human immune system.

研究类型

观察性的

注册 (实际的)

1888

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Maryland
      • Bethesda、Maryland、美国、20892
        • National Institutes of Health Clinical Center, 9000 Rockville Pike

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人
  • 年长者

接受健康志愿者

有资格学习的性别

全部

描述

  • INCLUSION CRITERIA:
  • Free of acute and chronic diseases (especially GI disorders) as determined by medical history, physical examination and laboratory tests.
  • Individuals may be taking antacids and/or laxative drugs but they must be discontinued 3 or more weeks before admission.
  • Age 18-45 years (in order to minimize the effect of aging on nutrient absorption).
  • BMI 18-25 kg/m(2) or greater than 35 kg/m(2).

EXCLUSION CRITERIA:

  • History or clinical manifestation of:

    1. Current smoking
    2. Type 2 diabetes (according to the World Health Organization diagnostic criteria)
    3. Endocrine disorders, such as Cushing's disease, pituitary disorders, and hypo- and hyperthyroidism
    4. HIV infection (self-report), due to effects on weight and body composition of HIV and medications used to treat HIV
    5. Active tuberculosis (self-report)
    6. Pulmonary disorders, including physician diagnosed chronic obstructive pulmonary diseases and obstructive sleep apnea syndrome; only subjects with mild or exercise-induced asthma on no medications or on beta-adrenergic agonists only (such as albuterol) will be allowed to enter the study
    7. Cardiovascular diseases, including coronary heart disease, heart failure, arrhythmias, and peripheral artery disease
    8. Hypertension (according to the World Health Organization diagnostic criteria), treated or uncontrolled
    9. Gastrointestinal disease, including inflammatory bowel diseases (e.g. Crohn's disease and ulcerative colitis), malabsorption syndromes (e.g. celiac disease), gastric ulcer (active)
    10. Lactose intolerance
    11. Liver disease, including non-alcoholic fatty liver disease, AST or ALT greater than 1.5 x normal value, cirrhosis, active hepatitis B or C
    12. Renal disease, as defined by serum creatinine concentrations greater than 1.5 mg/dl and/or overt proteinuria
    13. Central nervous system disease, including previous history of cerebrovascular accidents, dementia, and neurodegenerative disorders
    14. Cancer requiring treatment in the past five years, except for non-melanoma skin cancers or cancers that have clearly been cured or, in the opinion of the investigator, carry an excellent prognosis
  • Behavioral or psychiatric conditions that would be incompatible with a safe and successful participation in the study (such as major depression, schizophrenia and presence of psychotic symptoms)
  • Taking weight loss drugs
  • Use of any antibiotic or probiotic agents within the 2 months prior to the study
  • Evidence of alcohol and/or drug abuse (more than 3 drinks per day and use of drugs, such as amphetamines, cocaine, heroin, or marijuana)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2000年6月8日

研究完成

2013年3月21日

研究注册日期

首次提交

2006年8月1日

首先提交符合 QC 标准的

2006年8月1日

首次发布 (估计)

2006年8月2日

研究记录更新

最后更新发布 (实际的)

2019年12月17日

上次提交的符合 QC 标准的更新

2019年12月14日

最后验证

2013年3月21日

更多信息

与本研究相关的术语

其他研究编号

  • 000143
  • 00-I-0143

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅